EI- Nile Co. for Pharmaceuticals and Chemical Industries (EGX:NIPH)
Egypt
· Delayed Price · Currency is EGP 97.75
+1.19 (1.23%)
At close: Dec 3, 2025
EGX:NIPH Ratios and Metrics
Market cap in millions EGP. Fiscal year is July - June.
Millions EGP. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 2, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Market Capitalization | 2,888 | 1,465 | 699 | 405 | 359 | 354 | Upgrade
|
| Market Cap Growth | 412.94% | 109.54% | 72.69% | 12.78% | 1.40% | 14.77% | Upgrade
|
| Enterprise Value | 3,855 | 2,282 | 1,009 | 670 | 317 | 305 | Upgrade
|
| Last Close Price | 96.27 | 32.01 | 16.84 | 9.08 | 7.38 | 6.76 | Upgrade
|
| PE Ratio | 22.97 | 11.65 | 7.75 | 3.40 | 4.00 | 5.50 | Upgrade
|
| PS Ratio | 2.24 | 1.14 | 0.61 | 0.40 | 0.41 | 0.47 | Upgrade
|
| PB Ratio | 3.89 | 1.97 | 1.49 | 0.85 | 0.83 | 0.95 | Upgrade
|
| P/TBV Ratio | 3.89 | 1.97 | 1.49 | 0.85 | 0.83 | 0.95 | Upgrade
|
| P/FCF Ratio | - | - | - | - | - | 4.72 | Upgrade
|
| P/OCF Ratio | 3092.19 | 1568.74 | 2.65 | - | 73.13 | 4.46 | Upgrade
|
| EV/Sales Ratio | 2.99 | 1.77 | 0.88 | 0.67 | 0.36 | 0.40 | Upgrade
|
| EV/EBITDA Ratio | 12.52 | 7.41 | 6.49 | 1.36 | 2.28 | 2.84 | Upgrade
|
| EV/EBIT Ratio | 13.80 | 8.17 | 7.03 | 4.11 | 2.53 | 3.19 | Upgrade
|
| EV/FCF Ratio | -8.15 | - | - | - | - | 4.07 | Upgrade
|
| Debt / Equity Ratio | 1.33 | 1.33 | 1.23 | 0.44 | 0.19 | 0.12 | Upgrade
|
| Debt / EBITDA Ratio | 3.21 | 3.21 | 3.70 | 0.43 | 0.57 | 0.40 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | - | 0.58 | Upgrade
|
| Asset Turnover | 0.68 | 0.68 | 0.91 | 1.11 | 1.18 | 1.08 | Upgrade
|
| Inventory Turnover | 1.82 | 1.82 | 2.08 | 2.26 | 2.62 | 2.09 | Upgrade
|
| Quick Ratio | 0.38 | 0.38 | 0.35 | 0.47 | 0.57 | 0.74 | Upgrade
|
| Current Ratio | 0.98 | 0.98 | 1.28 | 1.75 | 1.81 | 1.75 | Upgrade
|
| Return on Equity (ROE) | 20.75% | 20.75% | 19.05% | 26.22% | 22.36% | 18.16% | Upgrade
|
| Return on Assets (ROA) | 9.20% | 9.20% | 7.14% | 11.25% | 10.53% | 8.54% | Upgrade
|
| Return on Capital (ROIC) | 12.58% | 12.58% | 10.34% | 16.93% | 16.95% | 15.00% | Upgrade
|
| Return on Capital Employed (ROCE) | 25.00% | 25.00% | 17.80% | 30.10% | 28.90% | 25.50% | Upgrade
|
| Earnings Yield | 4.35% | 8.58% | 12.90% | 29.44% | 24.98% | 18.19% | Upgrade
|
| FCF Yield | -16.38% | -32.28% | -22.25% | -70.16% | -12.21% | 21.21% | Upgrade
|
| Dividend Yield | 2.08% | 6.25% | 22.04% | 55.09% | 40.27% | 29.57% | Upgrade
|
| Payout Ratio | 39.41% | 39.41% | 71.36% | 34.95% | 37.13% | 70.73% | Upgrade
|
| Buyback Yield / Dilution | -196.30% | -196.30% | - | - | - | - | Upgrade
|
| Total Shareholder Return | -194.22% | -190.05% | 22.04% | 55.09% | 40.27% | 29.57% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.